TiZANidine
What is Ontralfy (TiZANidine)?
Approved To Treat
Related Clinical Trials
Objective: To measure postoperative pain control in patients in two treatment arms of ORIF of the clavicle: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen. Study
Summary: This study investigates the effects of Tizanidine on the voluntary movement controls of the arms of participants who have had a stroke and have not had a stroke by measuring medication-induced changes in upper extremity kinematics, pupillometry, and brain activity. Tizanidine is approved by the U.S. Food and Drug Administration. Understanding how different areas of the brain are involved in moveme...
Summary: The goal of this clinical trial is to evaluate whether adding tizanidine to the standard postoperative pain regimen improves recovery after pelvic reconstructive surgery in adult women. The main questions it aims to answer are: Does postoperative tizanidine improve patient-reported recovery 4-6 weeks after surgery? Does tizanidine reduce postoperative pain, opioid use, constipation, and healthcare...
Related Latest Advances
Brand Information
- taking strong CYP1A2 inhibitors
- with a history of hypersensitivity to tizanidine or the ingredients in Ontralfy. Symptoms have included anaphylaxis and angioedema
- Hypotension
- Liver Injury
- Sedation
- Hallucinosis/Psychotic-Like Symptoms
- Hypersensitivity Reactions
- Withdrawal Adverse Reactions


